Tower Research Capital LLC (Trc) Petros Pharmaceuticals, Inc. Transaction History

Tower Research Capital LLC (Trc)

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.68 - $1.49 $2,668 - $5,846	-3,924 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$1.07 - $3.36 $757 - $2,378	708 Added 22.01%	3,924 $6,000
Q4 2021 Feb 14, 2022	BUY	$1.33 - $4.09 $4,144 - $12,744	3,116 Added 3116.0%	3,216 $11,000
Q3 2021 Nov 15, 2021	BUY	$1.82 - $3.2 $20 - $35	11 Added 12.36%	100 $0
Q2 2021 Aug 16, 2021	BUY	$2.87 - $4.11 $255 - $365	89 New	89 $0

Ticker PTPI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 20,708,000
Market Cap $6.42M
Description
Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a patented topical formulation candidate for th...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.